Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6244133 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL3185955 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL1893030 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL27839473 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL139552 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL2168028 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL10548181 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL3180143 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| Hydrochloric Acid SCHEMBL6224383 | 0.96 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL4506405 | 0.96 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507670-B2 | Matrix metalloproteinase inhibitors | RANBAXY LABORATORIES LIMITED (IN) | 2013-08-13 | — | — | US | claimed |
| CN-109563242-B | Method for producing polymer compound | 住友化学株式会社 | 2021-08-31 | — | — | CN | disclosed |
| EP-3197905-B1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT INT LTD (CH) | 2021-06-30 | — | — | EP | disclosed |
| EP-3489274-A1 | POLYMER COMPOUND PRODUCTION METHOD | Sumitomo Chemical Company Limited (JP) | 2019-05-29 | — | — | EP | disclosed |
| EP-3197905-A1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | Clariant Plastics & Coatings Ltd (CH) | 2017-08-02 | — | — | EP | disclosed |
| EP-2379575-B1 | HYDROPHOSPHORYLATION OF PHOSPHONIC ACID DERIVATIVES TO YIELD FLAME RETARDANTS | CLARIANT INT LTD (CH) | 2017-04-12 | — | — | EP | disclosed |
| WO-2016045976-A1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT INTERNATIONAL LTD (CH) | 2016-03-31 | — | — | WO | disclosed |
| US-9279085-B2 | Method for the production of monofunctionalized dialkylphosphinic acids, esters and salts, and use thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2016-03-08 | — | — | US | disclosed |
| EP-2379572-B1 | METHOD FOR THE PRODUCTION OF MONOFUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, ESTERS, AND SALTS, AND USE THEREOF | CLARIANT INT LTD (CH) | 2015-12-23 | — | — | EP | disclosed |
| US-9181487-B2 | Process for preparing ethylenedialkylphosphinic acids, esters and salts by means of acetylene and use thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-11-10 | — | — | US | disclosed |
| US-20100081610-A1 | MATRIX METALLOPROTEINASE INHIBITORS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2010-04-01 | — | — | US | disclosed |
| EP-2074093-A2 | MATRIX METALLOPROTEINASE INHIBITORS | Ranbaxy Laboratories Limited (IN) | 2009-07-01 | — | — | EP | disclosed |
| US-20090048413-A1 | Method for Production of Conjugated Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-19 | — | — | US | disclosed |
| WO-2009010188-A2 | ALKYLPHOSPHONOUS ACIDS, SALTS AND ESTERS, METHODS FOR THE PRODUCTION THEREOF, AND USE OF SAME | CLARIANT INTERNATIONAL LTD (CH) | 2009-01-22 | — | — | WO | disclosed |
| EP-1997844-A1 | METHOD FOR PRODUCTION OF CONJUGATED POLYMER | Sumitomo Chemical Company, Limited (JP) | 2008-12-03 | — | — | EP | disclosed |
| US-20080194565-A1 | 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2008-08-14 | — | — | US | disclosed |
| WO-2008023336-A2 | MATRIX METALLOPROTEINASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2008-02-28 | — | — | WO | disclosed |
| EP-1856063-A1 | 5-PHENYL-PENTANOIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FOR THE TREATMENT OF ASTHMA AND OTHER DISEASES | Ranbaxy Laboratories Limited (IN) | 2007-11-21 | — | — | EP | disclosed |
| WO-2006090235-A1 | 5-PHENYL-PENTANOIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FOR THE TREATMENT OF ASTHMA AND OTHER DISEASES | RANBAXY LABORATORIES LIMITED (IN) | 2006-08-31 | — | — | WO | disclosed |
| US-4230719-A | Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain | TOYAMA CHEMICAL CO., LTD. (JP) | 1980-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081610-A1 | MATRIX METALLOPROTEINASE INHIBITORS | MMP9, MMP8, MMP12 | ALDH1A1 1056/4885HSD17B10 448/4885MGLL 2490/4885 |
| US-20080194565-A1 | 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases | F2RL3, ACOX3, LPAR5 | ALDH1A1 2132/4885HSD17B10 813/4885MGLL 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.